Jump to content

Biomedical Technology

EU Funded

Graphene for healthcare applications 

As the demand for healthcare services continues to increase, so does the demand for novel healthcare solutions. These solutions should be more effective, cost less, prevent and cure disease, and should be equally effective throughout the world. Graphene is paving the way for novel diagnosis and treatments, thanks to its unique properties, such as high surface area, electron mobility, and functionalisation potential; all favourable for biomedical technologies.

For instance, the surface area of graphene makes an excellent platform for drug delivery and the conductivity makes for effective biosensors. The ability of graphene to be made into scaffolds whilst maintaining the inherent conductivity can be put to use in tissue engineering. New research has shown that graphene can be incorporated with a polymer to make very sensitive electromechanical sensors, and that it can be used to make improved deep brain implants.

The most advanced and promising areas in the biomedical field are currently those where graphene is used in a device configuration. For example, in Point-of-Care or In Vitro diagnostics, graphene can be used as a sensor and be duly functionalized to tune its sensing capabilities. Graphene-based neural interfaces have also demonstrated the possibility to not only detect wavelengths in the brain that cannot be detected with current metal-based technologies, but also to stimulate the tissue, opening up possibilities for new therapies.

​Cinzia Spinato, Business Developer for biomedical applications for the Graphene Flagship

Graphene Biomedical Products

From graphene-based retinal implants to robotic prosthetic hands controlled by wearable sensors made by cellulose and graphene composites. Graphene Flagship researchers are using graphene to expand the realm of possibility within the biomedical sector.

The latest on Biomedical Technology

Graphene Flagship sign
Our project / Milestones / Innovation

Ten years of research, innovation and collaboration: the Graphene Flagship and the 2DM community

The Graphene Flagship was funded to ensure that Europe would maintain its lead in graphene research and innovation following the scientific breakthrough of graphene’s isolation at the University of Manchester. The European Commission launched the unprecedented long-term and large-scale Flagship research initiatives to tackle major challenges in science and technology, bringing positive changes that benefit society and the economy and advance European leadership in technology and industry. A decade on, we are proud to say that the Graphene Flagship has delivered on its promise. The clearly achieved objectives within scientific excellence, as well as societal and economic impact are detailed inside these pages.

By Graphene Flagship / 11 December 2023
Show all news